im cannabis - IMCC

IMCC

Close Chg Chg %
1.96 0.16 7.91%

Open Market

2.12

+0.16 (7.91%)

Volume: 52.01K

Last Updated:

Sep 9, 2026, 12:24 PM EDT

Company Overview: im cannabis - IMCC

IMCC Key Data

Open

$2.04

Day Range

1.89 - 2.15

52 Week Range

1.85 - 77.10

Market Cap

$203.60K

Shares Outstanding

102.85K

Public Float

90.73K

Beta

2.10

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$62.81

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

116.76K

 

IMCC Performance

1 Week
 
-1.01%
 
1 Month
 
-47.61%
 
3 Months
 
-71.88%
 
1 Year
 
-96.68%
 
5 Years
 
-99.97%
 

IMCC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About im cannabis - IMCC

IM Cannabis Corp. engages in the production and sale of medical cannabis products. It offers dry flower products and cannabis oil products under the IMC brand. The company was founded on March 7, 1980 and is headquartered in Glil Yam, Israel.

IMCC At a Glance

IM Cannabis Corp.
Kibbutz
Glil Yam, Tel Aviv 46905
Phone 972-77-444-2333 Revenue 39.17M
Industry Agricultural Commodities/Milling Net Income -8,100,688.92
Sector Process Industries Employees 44
Fiscal Year-end 12 / 2026
View SEC Filings

IMCC Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.15
Price to Book Ratio N/A
Price to Cash Flow Ratio 3.75
Enterprise Value to EBITDA -6.646
Enterprise Value to Sales 0.394
Total Debt to Enterprise Value 0.769

IMCC Efficiency

Revenue/Employee 890,214.372
Income Per Employee -184,106.566
Receivables Turnover 4.137
Total Asset Turnover 1.554

IMCC Liquidity

Current Ratio 0.669
Quick Ratio 0.482
Cash Ratio 0.097

IMCC Profitability

Gross Margin 14.136
Operating Margin -9.501
Pretax Margin -21.301
Net Margin -20.681
Return on Assets -32.145
Return on Equity -1,752.654
Return on Total Capital -88.57
Return on Invested Capital -775.357

IMCC Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 129.752
Total Debt to Total Assets 51.257
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 7.897
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Im Cannabis - IMCC

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
41.74M 36.16M 39.44M 39.17M
Sales Growth
-3.63% -13.36% +9.07% -0.69%
Cost of Goods Sold (COGS) incl D&A
34.46M 31.08M 34.86M 33.63M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
5.63M 2.22M 1.59M 1.40M
Depreciation
3.83M 917.25K 589.07K 442.29K
Amortization of Intangibles
1.80M 1.30M 1.01M 957.57K
COGS Growth
-15.65% -9.80% +12.17% -3.52%
Gross Income
7.28M 5.08M 4.58M 5.54M
Gross Income Growth
+195.75% -30.21% -9.86% +20.91%
Gross Profit Margin
+17.44% +14.05% +11.61% +14.14%
2022 2023 2024 2025 5-year trend
SG&A Expense
27.32M 14.10M 9.69M 9.26M
Research & Development
- - - -
-
Other SG&A
27.32M 14.10M 9.69M 9.26M
SGA Growth
-29.64% -48.39% -31.26% -4.48%
Other Operating Expense
- - - -
-
Unusual Expense
- 3.61M 457.14K (145.99K)
EBIT after Unusual Expense
(23.65M) (9.48M) (4.97M) (3.72M)
Non Operating Income/Expense
5.15M 5.19M (1.11M) (2.12M)
Non-Operating Interest Income
5.15M 5.19M 1.25M 2.46M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
1.51M 2.72M 3.26M 2.51M
Interest Expense Growth
+15.24% +79.56% +19.86% -23.12%
Gross Interest Expense
1.51M 2.72M 3.26M 2.51M
Interest Capitalized
- - - -
-
Pretax Income
(20.02M) (7.01M) (9.34M) (8.34M)
Pretax Income Growth
-39.33% +65.00% -33.28% +10.66%
Pretax Margin
-47.96% -19.38% -23.68% -21.30%
Income Tax
(874.14K) 571.24K (746.74K) 65.84K
Income Tax - Current - Domestic
516.19K 279.32K (637.24K) 183.93K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(1.39M) 291.92K (109.49K) (118.09K)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(19.14M) (7.58M) (8.59M) (8.41M)
Minority Interest Expense
(1.85M) (540.87K) (865.72K) (308.45K)
Net Income
(17.29M) (7.04M) (7.73M) (8.10M)
Net Income Growth
-22.05% +59.30% -9.80% -4.84%
Net Margin Growth
-41.43% -19.46% -19.59% -20.68%
Extraordinaries & Discontinued Operations
- - - (127.80M)
-
Discontinued Operations
- - - (127.80M)
-
Net Income After Extraordinaries
(145.09M) (7.04M) (7.73M) (8.10M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(145.09M) (7.04M) (7.73M) (8.10M)
EPS (Basic)
-3636.9267 -98.8136 -98.6688 -57.3253
EPS (Basic) Growth
-726.62% +97.28% +0.15% +41.90%
Basic Shares Outstanding
39.89K 71.22K 78.31K 141.31K
EPS (Diluted)
-3636.9267 -98.8136 -98.6688 -57.3253
EPS (Diluted) Growth
-283.31% +97.28% +0.15% +41.90%
Diluted Shares Outstanding
39.89K 71.22K 78.31K 141.31K
EBITDA
(14.41M) (6.80M) (3.52M) (2.32M)
EBITDA Growth
+54.68% +52.81% +48.26% +34.03%
EBITDA Margin
-34.53% -18.81% -8.92% -5.93%

Im Cannabis in the News